I’ve covered Dividend Stocks before, both Aristocrats and Kings, and am unhesitantly returning to them for a good reason. Dividend stocks should be a significant element of any investment strategy. Growth stocks are a terrific method to build wealth over time, but adding dividend stocks to the mix offers a steady income stream. You have the option of using that money to assist in paying for your living needs or reinvesting it in your portfolio. In any case, such consistent payments are a victory for investors, especially in today’s volatile marketplace.
When it comes to dividend stocks, care is essential. Some faltering businesses will pay a large dividend in the hopes of luring investors who might otherwise stay away. As a result, a high dividend yield might be a red flag. However, it is feasible to locate dividend stocks that provide a high dividend yield while still being a reliable investment. That’s what I’m going to attempt to do here.
Let’s look at three dividend-paying, buy-rated growth stocks that the analysts consider to be innovative portfolio picks:
Gilead Sciences Inc (GILD)
Beginning in 2020, biopharmaceutical stocks were significant in many portfolios. Many investors were betting on companies in the hopes of winning the race to produce a vaccine. Gilead Sciences (GILD) is a biopharmaceutical company that is very distinct from the others. GILD is a well-known corporation with more than $80 billion market capitalization. GILD has a medication (remdesivir) used in pandemic-related treatment, but it also has a well-established range of HIV, hepatitis, and influenza therapies.
Gilead provides a handsome quarterly dividend to its stockholders, currently paying a dividend yield of 4.6%. Although its year-over-year numbers aren’t as robust as they could be, GILD bested analysts’ expectations for the past three consecutive fiscal quarters on revenue. Until GILD reports again, its current quarter shows us an impressive $6.3 billion in sales, with an EPS (Earnings-per-share) of $1.80 per share. The consensus price target for GILD from the analysts that provide 12-month predictions is 75.00, with a high of 90.00 and a low of 62.00. The forecast is up 21.03% from current pricing, and the consensus among experts is to buy and hold stock in GILD.
LyondellBasell Industries (LYB)
LyondellBasell (LYB) is a petrochemical behemoth based in the Netherlands. The corporation is the world’s leading manufacturer of polypropylene compounds and one of the world’s foremost makers of plastics and chemicals. Whatever your feelings about plastics, polypropylene is an essential component of numerous industrial processes, including automobiles, home goods, and building materials. Demand for the material has helped LYB stock rise 7.8% in the last year.
LYB‘s commitment to compensating shareholders with regular, quarterly dividend payments has never wavered, just as the world’s need for plastics and chemicals hasn’t. LYB now pays a dividend yield of 4.5%. LYB’s current quarter shows us $11.9 billion in sales, at an impressive $3.59 per share. Like GILD, LYB has bested expert projections regarding revenue for the past three quarters. LYB has a consensus price target of 113.00 among the analysts that provide 12-month price estimates, with a high of 135.00 and a low of 92.00. The median estimate implies an increase of 10.62% from its previous price, and analysts agree to buy and hold LYB.
OneMain Holdings Inc (OMF)
OneMain Holdings, Inc. (OMF) is a consumer finance firm that specializes in non-prime personal loan origination, underwriting, and servicing. Through its integrated branch network, digital platform, and centralized operations, OMF provides secured and unsecured personal loans, optional credit and non-credit insurance, and associated products. The firm was established on August 5th, 2013, in Evansville, Indiana.
OMF is doing well. The firm released its fourth-quarter and full-year 2021 results recently. OMF’s net income for the year was $1.3 billion, up 78% from the previous year. The spectacular quarter contained an announcement that would pique the interest of any dividend stock seeker. OMF‘s usual quarterly dividend payout would be increased by 36% to 95 cents per share. OMF currently pays an impressive dividend yield of 7.1%. OMF bested Wall St’s EPS expectations for the past consecutive four quarters, and its year-over-year numbers indicate further growth. OMF’s current quarter shows us $1.1 billion in sales so far, at $2.20 per share. The consensus price target for OMF from analysts that provide 12-month predictions is 72.00, with a high of 87.00 and a low of 60.00. The forecast reflects an increase of 34.43% over current pricing, and the consensus gives OMF a strong buy rating.